CVS Health Corporation (CVS) Shares Up Significantly After Jim Cramer Said He Was Looking For A Good Year
CVS Health Corporation's shares have risen significantly, with a 55% increase over the past year and 30% year-to-date, attributed to improving business conditions and the company's robust Q1 earnings report. Jim Cramer highlighted CVS as a top performer in the healthcare sector, recovering strongly under its new CEO, David Joyner, while its competitor Walgreens faced store closures. The company also raised its full-year profit outlook beyond analyst estimates.
Jim Cramer on Cardinal Health: “It’s Been a Real Stalwart, and I Don’t Think It’s Done”
Jim Cramer expressed confidence in Cardinal Health (NYSE: CAH), recommending it to investors and stating that the stock deserves to trade higher despite a recent rotation out of healthcare. He highlighted the company's strong performance in a recent quarter. Cardinal Health supplies branded and generic medicines, and medical products.
Strs Ohio Has $55.25 Million Stock Position in CVS Health Corporation $CVS
Strs Ohio has reduced its holdings in CVS Health Corporation by 13.4% in the first quarter, now owning 769,277 shares valued at approximately $55.25 million. Despite this reduction, Wall Street analysts maintain a "Moderate Buy" rating for CVS, with a consensus target price of $101.28. The company recently reported strong quarterly results, surpassing earnings and revenue estimates, and raised its full-year 2026 EPS guidance.
Kroger breaks its promise on animal welfare
Kroger has failed to fulfill its 2016 commitment to sell only cage-free eggs by 2025, despite having a decade to do so and many competitors meeting similar goals. The company's inaction is seen as a betrayal of consumer trust, as evidenced by a recent poll showing 83% of Kroger shoppers reacted negatively to the broken promise. Humane World for Animals is urging Kroger's CEO, Greg Foran, to honor its animal welfare commitments and provide a clear plan for transitioning to 100% cage-free eggs.
Pardon the Disruption: Is Kroger’s acquisition of Giant Eagle worth the trouble?
Kroger's $1.65 billion acquisition of regional grocer Giant Eagle marks a return to its classic M&A strategy, but the author questions the compelling nature of the benefits. While the deal expands Kroger's footprint into new markets like Pennsylvania, Giant Eagle doesn't appear to offer unique assets or significant differentiation from Kroger's existing banners. The acquisition presents challenges for Kroger, which will need to improve Giant Eagle's performance while simultaneously working on its own business, though analysts acknowledge the value in building economies of scale and gaining entry into new territories at a reasonable price, despite investor skepticism.
CVS Health Corp. focuses on pharmacy and health services as investors watch the stock. Long-term str
CVS Health Corp. operates a diversified business combining retail pharmacies with health insurance and care services, making it a key player in the US healthcare system. Investors examine the company's financial performance, strategic integration of its various segments, and how it navigates competitive and regulatory landscapes. The stock's long-term prospects are tied to its ability to adapt to policy changes, meet evolving consumer demands, and effectively manage its integrated model.
Louisiana State Employees Retirement System Purchases Shares of 56,600 HA Sustainable Infrastructure Capital, Inc. $HASI
The Louisiana State Employees Retirement System has initiated a new position in HA Sustainable Infrastructure Capital, Inc. (HASI), acquiring 56,600 shares valued at approximately $2.08 million in the first quarter. This comes as HASI reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and declared a quarterly dividend of $0.425 per share. Analysts generally hold a "Moderate Buy" rating for HASI, with an average price target of $46.90.
Listerine Smart Rinse from Kenvue Inc. - kid-focused mouthwash adds fluoride and flavor
Kenvue Inc. (NYSE: KVUE) markets Listerine Smart Rinse, a fluoride-containing mouthwash designed for children aged six and older. This product, featuring 0.02% sodium fluoride and kid-friendly flavors, aims to strengthen tooth enamel and build oral care habits. Widely available at major US retailers for around $4.49, it positions itself as an adjunct to brushing, distinguishing itself from adult Listerine with lower alcohol content and visual cues for cleaning effectiveness.
CVS Health strategy shifts toward GLP-1 demand, shares stay anchored in the S&P 500
CVS Health is strategically leveraging its extensive pharmacy network to meet the growing demand for GLP-1 weight-loss and diabetes drugs, positioning itself strongly against competitors like Walmart and Walgreens. The company's integrated model, which combines PBM operations, insurance via Aetna, and retail pharmacies, creates multiple touchpoints for patients and aims to drive future prescription growth and ancillary health services. CVS Health remains a significant player in the S&P 500, with investors comparing its performance to other major retail and healthcare entities.
The Friday Checkout: Kroger, ADUSA and Hy-Vee are teaming up on health. Could that be a shot in the arm for the industry?
Kroger, Ahold Delhaize USA (ADUSA), and Hy-Vee are collaborating on a "Nourishing Change" initiative, including a conference planned for next year in Washington, D.C., to promote health and community well-being. This partnership aims to demonstrate the continued relevance of traditional grocery retailers in a changing market and to address food-related health problems collectively. While rivals often compete fiercely, this collaboration highlights the potential for joint efforts to counter challenges from large retailers like Walmart and Costco, though not all major players, such as Albertsons, are participating.
FY2026 EPS Estimates for Worthington Steel Raised by KeyCorp
KeyCorp raised its FY2026 EPS estimate for Worthington Steel (NYSE:WS) from $2.15 to $2.16, maintaining an "Overweight" rating and a $46 price target. The firm also initiated a FY2027 EPS projection of $2.50. This comes after Worthington Steel reported strong Q1 results, with an EPS of $0.74 topping estimates, though revenue of $929.2 million fell short of expectations.
Edgewell Spurns A $30 Offer As Consumer Stocks Diverge
Edgewell Personal Care rejected a $30-per-share offer from Yellow Wood Partners, leading to a jump in its stock price as the market began to price in the possibility of a higher bid. This event highlights how consumer stocks are diverging, with staples and discretionary spending items moving independently, and how an acquisition offer, even if rejected, can serve as a significant valuation marker for a company.
Bath & Body Works Partners with Ulta Beauty for Nationwide Retail Expansion - News and Statistics
Bath & Body Works is expanding its retail presence by partnering with Ulta Beauty, launching products in over 600 stores nationwide on July 12. This
Two Harbors, UWM trade sharp emails ahead of CCM merger vote
Executives from Two Harbors Investment Corp. (TWO) and United Wholesale Mortgage (UWM) exchanged heated emails regarding the proposed merger between Two Harbors and CrossCountry Mortgage (CCM). The correspondence, disclosed in SEC filings, indicates significant shareholder opposition to the CCM deal, with 54% of votes against it as of June 15. UWM's CEO, Mat Ishbia, has accused Two Harbors executives of prioritizing personal compensation over shareholder value, while Two Harbors maintains that UWM's proposals are not superior to the CCM all-cash offer.
AIG Beats Walgreens Opioid Claims in Latest Win for Insurers
An Illinois state court has ruled that American International Group (AIG) is not responsible for covering Walgreens' opioid-related lawsuits. The court found that the underlying claims against Walgreens do not allege damages "because of bodily injury," which is a requirement for coverage under AIG's commercial general liability and druggist professional liability umbrella policies from 1997 to 2013. This decision marks a significant win for insurers in the ongoing opioid litigation.
Amcon Distributing Co Today's Market Trends | DIT Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey
Amcon Distributing Co (DIT) shows relatively stable fundamentals and high growth potential, though its valuation is considered fair within the Food & Drug Retailing industry. The stock price has seen a decline over the past month and is currently trading sideways. The company is noted for being a high and stable dividend payer but faces risks due to being overvalued and institutional selling.
Kroger sells specialty pharmacy business to Elevance Health in 64M deal | RBCCM
Kroger has sold its specialty pharmacy business to CarelonRx, a subsidiary of Elevance Health, for $464 million. This divestiture allows Kroger to focus on its core grocery retail, in-store pharmacy, and healthcare offerings, while strengthening Elevance Health’s specialty pharmacy services. RBC Capital Markets acted as Kroger’s exclusive financial advisor, leveraging its cross-sector expertise to facilitate the transaction.
Yelp releases list of the fastest-growing brands in Ohio
Yelp analyzed user data from 2025 compared to 2024 to identify the fastest-growing brands in Ohio, considering new business openings, user searches, and interactions. Grocery Outlet, a discount grocery chain, was named Ohio's fastest-growing brand, followed by drive-thru coffee concept 7 Brew and chicken chain Wingstop. Smoothie King and Paris Baguette rounded out the top five in Ohio.
Citius Pharmaceuticals Inc (CTXR) Shareholder Structure: Major Shareholders & Institutional Holdings
This article provides an overview of Citius Pharmaceuticals Inc (CTXR) shareholder structure, detailing major individual and institutional shareholders. It presents data on the proportion of shares held by various entities and shareholder types, along with historical institutional shareholding trends and recent shareholder activity. The information is updated as of May 11, with institutional holdings updated April 1.
Cencora Inc (COR) Shareholder Structure: Major Shareholders & Institutional Holdings
This article details the shareholder structure of Cencora Inc (COR), outlining its major institutional and individual holders. It provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activity with changes in ownership, offering a comprehensive overview of the company's ownership landscape.
Aldi, Costco and Trader Joe’s are most trusted among shoppers
Aldi, Costco, and Trader Joe's are among the most trusted brands by shoppers, with Aldi leading the grocery store category in a recent study by Morning Consult. The research, which surveyed over 3,200 brands, found that household essentials like Dawn, Dove, and Heinz Ketchup also ranked highly. Conversely, artificial intelligence was identified as the least trusted category, and Gen Z showed the lowest brand trust across demographics.
Listerine Cool Mint: classic mouthwash with a fresh twist
This article provides an in-depth look at Listerine Cool Mint, a flagship antiseptic mouthwash from Kenvue, highlighting its features, target audience, and market positioning. It details how the product, with its strong mint flavor and essential oil formula, functions as a daily oral hygiene complement, widely available in the U.S. market. The article also mentions Kenvue's broader portfolio and the performance of its shares on the New York Stock Exchange.
Macquarie Group Ltd. Lowers Stock Position in CVS Health Corporation $CVS
Macquarie Group Ltd. reduced its stake in CVS Health Corporation by 10.1% in the fourth quarter of 2025, selling over 152,000 shares but still holding 1.36 million shares valued at about $107.5 million. This divestment occurred despite CVS Health's strong operational performance, including better-than-expected earnings and a raised FY2026 EPS guidance. While analyst sentiment is generally positive, significant insider selling, particularly by Director Larry Robbins and EVP Tilak Mandadi, has been noted.
Fiera Capital Corp Boosts Stock Position in Xenon Pharmaceuticals Inc. $XENE
Fiera Capital Corp increased its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) by 31.9% in the fourth quarter, bringing its total holdings to 686,056 shares valued at $30.7 million. Several other institutional investors also increased their positions, indicating significant institutional ownership (95.45%) in the biopharmaceutical company. Analysts maintain a "Buy" rating for Xenon with an average price target of $77.20, while the stock recently traded around $51.21 after reporting in-line quarterly EPS.
Ralph Lauren stock hits all-time high at 393.42 USD By Investing.com
Ralph Lauren (RL) stock has reached an all-time high of $393.42, reflecting robust investor confidence and strong performance. The company's market cap is $23.39 billion, with a 46.6% increase over the past year and impressive gross profit margins of nearly 70%. Recent financial results for fiscal 2026 were strong, with EPS and revenue surpassing expectations, leading to analysts raising price targets for the stock.
Humana stock reaches 52-week high at 361.21 USD
Humana Inc. (NYSE: HUM) stock has hit a new 52-week high of $361.21, trading just 1% above its previous high of $356.01, with a market capitalization of $43.19 billion. InvestingPro analysis suggests the stock is currently undervalued despite a 55.47% increase over the past year. Recent positive developments include reaffirmed fiscal 2026 EPS guidance, several analyst upgrades with increased price targets, and a significant grant commitment for healthcare initiatives.
Klarna Launches High-Yield Savings Account, Turning Everyday Spend Into Everyday Savings
Klarna has launched high-yield savings accounts in the U.S., offering FDIC-insured accounts with no minimum deposit, no monthly fees, and interest rates starting above 3% APY. These accounts are available directly in the Klarna app and are provided by WebBank, aiming to help Americans put their idle money to work given that the average American earns less than half a percent on their savings. This move expands Klarna's financial services, allowing users to manage their full financial life within one app.
CVS Pharmacy retail stores as everyday health hubs in the US
CVS Pharmacy retail stores serve as everyday health hubs in the US, offering prescriptions, vaccinations, and essential goods. These stores provide convenient access to health services for many American households. The article details the services provided by CVS Pharmacy, its importance to US consumers, and its position within the US pharmacy and retail market.
BI Asset Management Fondsmaeglerselskab A S Sells 12,763 Shares of CVS Health Corporation $CVS
BI Asset Management Fondsmaeglerselskab A S reduced its stake in CVS Health Corporation by 3.3% in the fourth quarter, selling 12,763 shares and holding 373,299 shares valued at $28,059,000. Other institutional investors made notable changes to their positions, with some increasing and others decreasing their holdings. Analyst ratings for CVS Health remain largely positive, with a "Moderate Buy" consensus and a price target of $99.88, despite recent insider share sales by EVP Tilak Mandadi and Director Larry Robbins.
Gang Ye Sells 10,000 Shares of SEA (NYSE:SE) Stock
Gang Ye, COO of Sea Limited (NYSE:SE), sold 10,000 shares of the company's stock on June 3rd for $904,700, reducing his holdings to 170,000 shares. This transaction is part of a consistent pattern of insider selling by Ye throughout May and early June. Despite mixed quarterly results where revenue beat estimates but EPS missed, analysts largely rate SEA as a "Moderate Buy" with an average price target of $155.54.
Chicago claims 14 Fortune 500 spots, led by ADM
Chicago is home to 14 companies featured in this year's Fortune 500 list. Archer-Daniels-Midland (ADM) is the highest-ranked local company at No. 58, following Walgreens no longer appearing on the list. Nearly 30 Illinois-based companies made the overall Fortune 500.
CVS Health Corp. stock (US1266501006): shares ease as investors digest latest moves in U.S. healthca
CVS Health Corp. shares traded lower on the New York Stock Exchange on June 3, 2026, declining over 2% to around $90.98, as investors assessed the company's strategic moves and broader U.S. healthcare market trends. The company's integrated structure, combining retail pharmacies, pharmacy benefit management, and health insurance, positions it uniquely against purely retail or insurance-focused rivals, a factor that influences market valuation. Future stock performance will likely be tied to U.S. policy decisions, prescription trends, and competitive dynamics within the American healthcare system.
Powering store readiness: How supply chain automation helps CVS Pharmacy move products with precision
CVS Pharmacy is utilizing advanced automation in its distribution centers, such as the one in Hainesport, New Jersey, to enhance the efficiency and precision of product movement to stores. This automation involves robots working alongside human colleagues to process millions of items weekly, focusing on health, beauty, and personal care products. The initiative aims to improve store readiness, operational efficiency, and overall reliability of the supply chain, allowing store teams to focus more on customer care.
Astrotech (NASDAQ: ASTC) launches $24,492,819 at-the-market stock plan
Astrotech Corporation has initiated an at-the-market (ATM) offering, allowing it to sell up to $24,492,819 worth of common stock through H.C. Wainwright & Co., LLC. The sales will be made under an existing S-3 shelf registration and a June 2, 2026 prospectus supplement, with Wainwright receiving a 3.0% commission. Astrotech is not obligated to sell any specific amount of shares, and the program will continue until all authorized shares are sold or the agreement is terminated.
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
Celcuity Inc. has announced a proposed underwritten public offering of $400,000,000 aggregate principal amount of convertible senior notes due 2032, with an option for underwriters to purchase an additional $60,000,000. The company plans to use the net proceeds to repay an existing loan agreement and for working capital and general corporate purposes, including potential acquisitions. The offering is subject to market conditions, and Jefferies, J.P. Morgan, TD Cowen, and Guggenheim Securities are acting as joint book-running managers.
Cencora (COR) Has a Specialty-Distribution Moat That Looks Stronger Than Its Thin Margins Suggest
Cencora (COR) possesses a strong competitive advantage in pharmaceutical distribution, particularly in specialty categories, despite its seemingly low operating margins. The company's increasing relevance is demonstrated by its robust Q2 2026 results, including revenue growth and rising operating income, driven by services beyond simple wholesale distribution. Its strategy involves moving up the value chain through manufacturer services, global commercialization, and strategic acquisitions like OneOncology, deepening its embedded role in the drug supply chain.
NRG Energy, Inc. $NRG Shares Purchased by BW Gestao de Investimentos Ltda.
BW Gestao de Investimentos Ltda. significantly increased its stake in NRG Energy by 94.9% in the fourth quarter, bringing its total holdings to 155,895 shares valued at approximately $24.8 million. Institutional investors collectively own 97.72% of NRG shares, and analysts generally maintain a "Moderate Buy" rating with a consensus price target of $199.69. The article also notes recent insider selling and mixed quarterly earnings results for NRG Energy.
Truist Financial Increases CVS Health (NYSE:CVS) Price Target to $108.00
Truist Financial has increased its price target for CVS Health (NYSE:CVS) to $108.00 from $102.00, maintaining a "buy" rating and suggesting a 19% upside. This follows strong Q1 earnings where CVS Health beat revenue and EPS expectations, leading analysts to update their price objectives for the pharmacy operator. Most analysts have a "buy" rating on the stock, with a consensus target price of $99.68.
RDGT - Ridgetech Inc Stock Price and Quote
This article provides comprehensive stock information for Ridgetech Inc (RDGT), including its last closing price, key financial metrics, performance indicators, and recent news headlines. It details the company's business segments in healthcare products, insider trading activities, and lists executive leadership. The data reflects a company with significant recent volatility and a history of corporate actions like reverse stock splits and direct offerings.
AI helps CVS pharmacists cut delays, earn Newsweek safety award
CVS Health received the 2026 Newsweek AI Impact Award in the AI Health Care category for Best Outcomes – Patient Care. The award recognizes CVS Health's AI-Driven Prescription Interpretation and Instruction Standardization technology, which uses large language models to interpret complex prescription directions and calculate precise dosage, reducing manual transcription and speeding up prescription fulfillment. This AI implementation allows pharmacists more time for direct patient support while maintaining their final clinical authority through "human-in-the-loop" safeguards.
Marsh & McLennan Companies (NYSE:MRSH) Trading Down 13.1% After Analyst Downgrade
Marsh & McLennan Companies (NYSE:MRSH) saw its stock price drop 13.1% after Piper Sandler lowered its price target from $190 to $182, maintaining a neutral rating. Despite recent better-than-expected quarterly earnings, several other analysts have also trimmed their price targets, though the stock retains an average "Hold" rating and a consensus target of $203.56. The decline was accompanied by higher-than-normal trading volume.
Burlington Stores Target of Unusually High Options Trading (NYSE:BURL)
Burlington Stores (NYSE:BURL) experienced unusually high options trading on Thursday, with investors purchasing 9,113 put options, significantly above the average volume, suggesting some traders are hedging against potential downside. This activity follows a sharp drop in BURL shares to $291.67, despite the company reporting strong first-quarter earnings, beating analyst expectations, and raising its full-year outlook. While management noted 14 consecutive quarters of double-digit EPS growth, concerns about higher startup costs for a new distribution center may be influencing investor sentiment and options behavior.
Ranch products recalled from NC Walmarts in ongoing salmonella issue
A popular Blackstone Parmesan Ranch seasoning sold at Walmart stores nationwide has been recalled due to potential salmonella contamination. This recall is linked to contaminated powdered milk from California Dairies, Inc., which has affected numerous products. Consumers are advised to dispose of the product and can contact Blackstone Products for a replacement.
CVS, Walgreens and Walmart defeat Florida hospitals' opioid lawsuit
A Florida judge has ruled in favor of CVS, Walgreens, and Walmart, dismissing a lawsuit from 16 Florida hospitals that accused the pharmacy chains of contributing to the opioid crisis. The judge found that the hospitals were not directly harmed by the pharmacy chains' alleged efforts to boost opioid sales, but rather indirectly through increased patient care costs. This decision follows a mistrial in late 2025 where jurors could not reach a verdict.
CVS Health Pushes Integrated Care With AI Claims And MinuteClinic Expansion
CVS Health is expanding its integrated care strategy by launching an AI-powered claims platform, Aetna Claims Assist Manager, and expanding MinuteClinic's primary care services with Hartford HealthCare. These initiatives aim to improve operational efficiency, provider satisfaction, and patient relationships by leveraging digital tools and tighter integration between CVS's insurance, pharmacy, and care delivery units. Despite strong recent share performance and growth forecasts, the company faces risks related to debt coverage and regulatory scrutiny.
General Electric (GE) | History, Acquisitions, Products, & Facts | Britannica Money
This article details the history of General Electric (GE), from its incorporation in 1892 as a conglomerate born from Thomas Edison's ventures to its recent transformation into a technology company focused on energy solutions, jet engines, and healthcare technologies. It covers key periods including the Jack Welch years, the company's financial struggles in the 2010s, and its subsequent strategic pivot and spin-offs. The piece highlights GE's continuous innovation and reinvention across various industrial and technological fields.
William Blair Investment Management LLC Sells 94,656 Shares of Sanmina Corporation $SANM
William Blair Investment Management LLC reduced its stake in Sanmina Corporation by 29.2% in the fourth quarter, selling 94,656 shares and retaining 229,362 shares valued at approximately $34.4 million. This move comes despite Sanmina reporting strong quarterly results, exceeding EPS and revenue estimates, and raising future guidance. However, insider selling, including by the CEO and a Director, totaled 157,532 shares worth $34.8 million in the last 90 days.
Legal & General Group Plc Sells 75,458 Shares of The TJX Companies, Inc. $TJX
Legal & General Group Plc reduced its stake in The TJX Companies, Inc. by 1.3% in the fourth quarter, selling 75,458 shares but still retaining 5.69 million shares valued at $874.8 million. This comes as TJX reported strong Q1 earnings, beating consensus EPS and revenue expectations, and raising its full-year guidance. Analysts maintain a "Buy" rating with an average price target of $174.58.
Northwestern Mutual Wealth Management Co. Acquires 55,412 Shares of Fastenal Company $FAST
Northwestern Mutual Wealth Management Co. significantly increased its stake in Fastenal Company (NASDAQ:FAST) during the fourth quarter, purchasing an additional 55,412 shares to bring its total holdings to 138,071 shares, valued at approximately $5.54 million. This move comes as Fastenal reported Q1 earnings that met analyst expectations and revenue that slightly topped estimates, growing 12.4% year over year. The company also declared a quarterly dividend of $0.24 per share, with several institutional investors also modifying their positions in Fastenal.
LSV Asset Management Sells 78,409 Shares of CVS Health Corporation $CVS
LSV Asset Management reduced its stake in CVS Health by 1.7% in the fourth quarter, selling 78,409 shares, but it remains a significant holding for the firm. Despite mixed analyst sentiment and recent insider selling, CVS Health maintains a "Moderate Buy" rating with a consensus price target of $98.68. The company has faced a lawsuit regarding the 340B drug program and has also seen positive news regarding its Medicare Advantage position and operational turnaround.
